| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |